Proprietary AI analyst is now available
- Public Comps
- Shu Yu Civilian Pharmacy
Shu Yu Civilian Pharmacy Valuation Multiples
Discover revenue and EBITDA valuation multiples for Shu Yu Civilian Pharmacy and similar public comparables like WH Smith, Nick Scali, Apotea, Guararapes and more.
Shu Yu Civilian Pharmacy Overview
About Shu Yu Civilian Pharmacy
Shu Yu Civilian Pharmacy Corp Ltd is primarily involved in the operation and sales of Chinese and Western patent medicines, health foods, Chinese herbal medicines, health equipment and other products.
Founded
1999
HQ

Employees
N/A
Website
Sectors
Financials (FY)
EV
$1B
Valuation Multiples
Start free trialShu Yu Civilian Pharmacy Financials
Shu Yu Civilian Pharmacy reported last fiscal year revenue of $2B and EBITDA of $105M.
In the same fiscal year, Shu Yu Civilian Pharmacy generated $399M in gross profit, $105M in EBITDA, and $17M in net income.
Shu Yu Civilian Pharmacy P&L
In the most recent fiscal year, Shu Yu Civilian Pharmacy reported revenue of $2B and EBITDA of $105M.
Shu Yu Civilian Pharmacy is profitable as of last fiscal year, with gross margin of 26%, EBITDA margin of 7%, and net margin of 1%.
Financial data powered by Morningstar, Inc.
Shu Yu Civilian Pharmacy Stock Performance
Shu Yu Civilian Pharmacy has current market cap of $847M, and enterprise value of $1B.
Market Cap Evolution
Shu Yu Civilian Pharmacy's stock price is $2.09.
Shu Yu Civilian Pharmacy share price increased by 2.3% in the last 30 days, and by 12.0% in the last year.
Shu Yu Civilian Pharmacy has an EPS (earnings per share) of $0.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $847M | -1.8% | 2.3% | -1.4% | 12.0% | $0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialShu Yu Civilian Pharmacy Valuation Multiples
Shu Yu Civilian Pharmacy trades at 0.7x EV/Revenue multiple, and 10.7x EV/EBITDA.
Shu Yu Civilian Pharmacy Financial Valuation Multiples
As of June 5, 2026, Shu Yu Civilian Pharmacy has market cap of $847M and EV of $1B.
Shu Yu Civilian Pharmacy has a P/E ratio of 50.2x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Shu Yu Civilian Pharmacy Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Shu Yu Civilian Pharmacy Margins & Growth Rates
In the most recent fiscal year, Shu Yu Civilian Pharmacy reported gross margin of 26%, EBITDA margin of 7%, and net margin of 1%.
Shu Yu Civilian Pharmacy Margins
Shu Yu Civilian Pharmacy Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Shu Yu Civilian Pharmacy Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Shu Yu Civilian Pharmacy Competitors
Shu Yu Civilian Pharmacy competitors include WH Smith, Nick Scali, Apotea, Guararapes, ARKO, Magalu, Guess, Mobilezone Holding, Doğuş Otomotiv and MAP Active.
Most Shu Yu Civilian Pharmacy public comparables operate across Pharmacies and Specialty Stores.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.1x | 1.0x | 8.2x | 7.9x | |||
| 2.9x | 2.7x | 9.0x | 7.9x | |||
| 1.1x | 1.0x | 16.6x | 15.3x | |||
| 0.6x | - | 2.1x | - | |||
| 0.4x | 0.4x | 11.9x | 12.0x | |||
| 0.3x | 0.3x | 4.0x | 3.9x | |||
| - | - | - | - | |||
| 0.6x | 0.9x | (190.9x) | 27.8x | |||
This data is available for Pro users. Sign up to see all Shu Yu Civilian Pharmacy competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Shu Yu Civilian Pharmacy
| When was Shu Yu Civilian Pharmacy founded? | Shu Yu Civilian Pharmacy was founded in 1999. |
| Where is Shu Yu Civilian Pharmacy headquartered? | Shu Yu Civilian Pharmacy is headquartered in China. |
| Is Shu Yu Civilian Pharmacy publicly listed? | Yes, Shu Yu Civilian Pharmacy is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Shu Yu Civilian Pharmacy? | Shu Yu Civilian Pharmacy trades under 301017 ticker. |
| When did Shu Yu Civilian Pharmacy go public? | Shu Yu Civilian Pharmacy went public in 2021. |
| Who are competitors of Shu Yu Civilian Pharmacy? | Shu Yu Civilian Pharmacy main competitors include WH Smith, Nick Scali, Apotea, Guararapes, ARKO, Magalu, Guess, Mobilezone Holding, Doğuş Otomotiv, MAP Active. |
| What is the current market cap of Shu Yu Civilian Pharmacy? | Shu Yu Civilian Pharmacy's current market cap is $847M. |
| What is the current revenue of Shu Yu Civilian Pharmacy? | Shu Yu Civilian Pharmacy's last fiscal year revenue is $2B. |
| What is the current EV/Revenue multiple of Shu Yu Civilian Pharmacy? | Current revenue multiple of Shu Yu Civilian Pharmacy is 0.7x. |
| Is Shu Yu Civilian Pharmacy profitable? | No, Shu Yu Civilian Pharmacy is not profitable. |
| How many companies Shu Yu Civilian Pharmacy has acquired to date? | Shu Yu Civilian Pharmacy hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Shu Yu Civilian Pharmacy has invested to date? | Shu Yu Civilian Pharmacy hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Shu Yu Civilian Pharmacy
Lists including Shu Yu Civilian Pharmacy
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.